Xuan Wei

Dr. Xuan Wei


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
XWXuan Wei
Xuan Wei
SWShiya Wang
Shiya Wang
MZMingkai Zhang
Mingkai Zhang
YYYing Yan
Ying Yan
ZWZheng Wang
Zheng Wang
ZWZhenchang Wang
Zhenchang Wang
Microstructural alterations in the brain networks of Parkinson’s disease (PD) patients are correlated with gait impairments. Evaluate microstructural alterations in the white matter (WM) fiber bundle tracts using neurite orientation dispersion and density imaging (NODDI) technique in PD versus healthy controls (HC). In this study, 24 PD patients and 29 HC were recruited. NODDI and high-resolution 3D structural images were acquired for each participant. The NODDI indicators, including the intracellular neurite density index (NDI), orientation dispersion index (ODI), and isotropic volume fraction (ISO), were compared between the two groups. Diffusion-weighted (DW) images were preprocessed using MRtrix 3.0 software and the orientation distribution function to trace the main nerve fiber tracts in PD patients. Quantitative gait and clinical assessment scales were used to compare the medication “ON” and “OFF” states of PD patients. The NDI, ODI, and ISO values of the WM fiber bundles were significantly higher in PD patients compared to HC. Fiber bundles, including the anterior thalamic radiation, corticospinal tract, superior longitudinal fasciculus, forceps major, cingulum, and inferior longitudinal fasciculus, were found to be significantly affected in PD. The NDI changes of PD patients were well correlated with stride lengths in the “ON” state; ODI changes were correlated with the stride time in the “ON” and “OFF” states and ISO changes were correlated with the stride time and cadence in the “ON” state. In conclusion, combination of NODDI technique and gait parameters can help detect gait impairment in PD patients early and accurately.

8 February 2019 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
XWXuan Wei
Xuan Wei
WLWei Li
Wei Li
JCJiajie Chen
Jiajie Chen
YLYongbin Li
Yongbin Li
JZJia Zhu
Jia Zhu
WWWei Wang
Wei Wang

1 December 2023 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
YYYing Yan
Ying Yan
ZWZheng Wang
Zheng Wang
WWWei Wei
Wei Wei
ZYZhenghan Yang
Zhenghan Yang
LGLingfei Guo
Lingfei Guo
XWXuan Wei
Xuan Wei
Background: Quantitative susceptibility mapping (QSM) is a novel imaging method for detecting iron content in the brain. The study aimed determine whether the iron deposition in the brains of people with Parkinson’s disease (PD) is correlated with freezing of gait (FOG). Methods: We retrospectively collected the data of 24 patients with PD from the Movement Disorders Program and 36 healthy controls (HCs) from January 2021 to December 2021. Clinical assessments included mental intelligence scales, Parkinson rating scales, motor-related scales, and clinical gait assessments. All exercise scales and gait assessments were performed in the “ON” and “OFF” states. Magnetic resonance imaging (MRI) data were collected using 3-dimensional fast low-angle shot sequences. We chose the bilateral red nucleus, substantia nigra, thalamus, putamen, caudate nucleus, and globus pallidus as regions of interest for QSM analysis. Results: The iron deposition in the substantia nigra of the PD group was significantly higher than that of the HC group (P<0.01). In the PD group, the iron deposition in the substantia nigra of patients with FOG was significantly higher than that in patients without FOG (P=0.04). The iron deposition in the substantia nigra was positively correlated with the New Freezing of Gait Questionnaire (P=0.03). The scores for depression and anxiety of the PD group were significantly higher than those of the HC group, while the Berg balance scale score was significantly lower (P<0.01). Conclusions: The iron deposition in the substantia nigra of patients with PD is increased compared with that of controls and is associated with FOG. QSM can be used to detect brain iron deposition in patients with PD, which would help to explore the mechanism of abnormal neurobiological activity in FOG.

1 July 2025 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
LDLining Dong
Lining Dong
WZWenyu Zhou
Wenyu Zhou
RARan An
Ran An
ZWZheng Wang
Zheng Wang
WWWei Wei
Wei Wei
XWXuan Wei
Xuan Wei
The specific mechanism underlying the effect of changes in brain iron content on the development of RBD secondary to PD remains unclear. 27 PD patients with secondary RBD (PD-RBD+), 24 PD patients without RBD (PD-RBD-), and 32 healthy controls (HCs) were included. Paramagnetic susceptibility was isolated using APART-QSM. The QSM and paramagnetic susceptibility (χpara) values of the whole brain and subcortical nuclei were compared among groups. The diagnostic performance was evaluated using receiver operating characteristic curve analysis. Compared with PD-RBD-, PD-RBD+ patients presented a lower χpara value in the left middle temporal gyrus. The QSM and χpara values of bilateral substantia nigra pars compacta (SNpc) were increased in both groups. The diagnostic performance of the combined index of χpara values was superior to that of the QSM value or the single index. In conclusion, paramagnetic susceptibility isolated from QSM is helpful for iron quantification and exploring the mechanism of PD-RBD+.

7 July 2025 in Military Medical Research
Verified
Journal Article
Open access
PDF file
MSMing-Jun Shi
Ming-Jun Shi
ZWZhi-Xiang Wang
Zhi-Xiang Wang
SWShuang-Kun Wang
Shuang-Kun Wang
XLXuan-Hao Li
Xuan-Hao Li
YZYan-Lin Zhang
Yan-Lin Zhang
ZWZhenchang Wang
Zhenchang Wang
Background: Multiparametric magnetic resonance imaging (mpMRI) has significantly advanced prostate cancer (PCa) detection, yet decisions on invasive biopsy with moderate prostate imaging reporting and data system (PI-RADS) scores remain ambiguous. Methods: To explore the decision-making capacity of Generative Pretrained Transformer-4 (GPT-4) for automated prostate biopsy recommendations, we included 2299 individuals who underwent prostate biopsy from 2018 to 2023 in 3 large medical centers, with available mpMRI before biopsy and documented clinical-histopathological records. GPT-4 generated structured reports with given prompts. The performance of GPT-4 was quantified using confusion matrices, and sensitivity, specificity, as well as area under the curve were calculated. Multiple artificial evaluation procedures were conducted. Wilcoxon’s rank sum test, Fisher’s exact test, and Kruskal–Wallis tests were used for comparisons. Results: Utilizing the largest sample size in the Chinese population, patients with moderate PI-RADS scores (scores 3 and 4) accounted for 39.7% (912/2299), defined as the subset-of-interest (SOI). The detection rates of clinically significant PCa corresponding to PI-RADS scores 2–5 were 9.4, 27.3, 49.2, and 80.1%, respectively. Nearly 47.5% (433/912) of SOI patients were histopathologically proven to have undergone unnecessary prostate biopsies. With the assistance of GPT-4, 20.8% (190/912) of the SOI population could avoid unnecessary biopsies, and it performed even better [28.8% (118/410)] in the most heterogeneous subgroup of PI-RADS score 3. More than 90.0% of GPT-4 -generated reports were comprehensive and easy to understand, but less satisfied with the accuracy (82.8%). GPT-4 also demonstrated cognitive potential for handling complex problems. Additionally, the Chain of Thought method enabled us to better understand the decision-making logic behind GPT-4. Eventually, we developed a ProstAIGuide platform to facilitate accessibility for both doctors and patients. Conclusions: This multi-center study highlights the clinical utility of GPT-4 for prostate biopsy decision-making and advances our understanding of the latest artificial intelligence implementation in various medical scenarios.

26 March 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
LZLingling Zhang
Lingling Zhang
XRXinyi Ren
Xinyi Ren
RARan An
Ran An
HSHongchen Song
Hongchen Song
YTYaqi Tian
Yaqi Tian
ZWZhenchang Wang
Zhenchang Wang
Prostate cancer (PCa) is one of the most common malignancies and the second leading cause of cancer-related death in men worldwide. The six-transmembrane epithelial antigen of the prostate 1 (STEAP1) is exceptionally overexpressed in PCa, maintaining high expression even in the castration-resistant prostate cancer (CRPC) stage, making it a promising target for diagnosis and treatment. STEAP1-positive extracellular vesicles and STEAP1-PET imaging are optimistic approaches for the non-invasive detection of different stages of PCa. STEAP1-targeted therapy includes an antibody–drug conjugate (ADC), chimeric antigen receptor T cell (CAR-T), T-cell engager (TCE), and vaccines, which demonstrate valuable therapeutic prospects. This review presents the structure and pathophysiological function of STEAP1, synthesizes cutting-edge advances in STEAP1-targeted molecular imaging and clinical applications, and critically analyzes their translational potential to overcome the limitations of current PCa diagnosis and treatment.